Liste des principales publications depuis 2004 (* articles en collaboration)

Selected references since 2004 (* collaborative papers)



Rodrigues-Ferreira S, Nehlig A, Monchecourt C, Nasr S, Fuhrmann L, Lacroix-Triki M, Garberis I, Scott V, Delaloge S, Pistilli B, Vielh P, Dubois T, Vincent-Salomon A, André F, Nahmias C. Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis. Breast Cancer Res Treat. Oct 27 (in press, 2018). 



Nehlig A, Molina A, Rodrigues-Ferreira S, Honoré S, Nahmias C. Regulation of end-binding protein EB1 in the control of microtubule dynamics. Cell Mol Life Sci. 74(13):2381-2393 (2017).


1. * Maria AG, Dillenburg-Pilla P, Reis RI, Floriano EM, Tefé-Silva C, Ramos SG, Pesquero JB, Nahmias C, Costa-Neto CM. Host kinin B1 receptor plays a protective role against melanoma progression. Sci Rep. 6: 22078 (2016). (*Bresil)




1. Velot L, Molina A, Rodrigues-Ferreira S, Nehlig A, Bouchet BP, Morel M, Leconte L, Serre L, Arnal I, Braguer D, Savina A, Honore S, Nahmias C. Negative regulation of EB1 turnover at microtubule plus ends by interaction with microtubule-associated protein ATIP3, Oncotarget, 6(41):43557-70 (2015).

2. Rodrigues-Ferreira S, Nahmias C. G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer? Front Pharmacol. 6:24 (2015).

3. * Izraely S, Sagi-Assif O, Klein A, Meshel T, Ben-Menachem S, Zaritsky A, Ehrlich M, Prieto VG, Bar-Eli M, Pirker C, Berger W, Nahmias C, Couraud PO, Hoon DS, Witz IP. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int J Cancer136(6):1296-307 (2015). (*Israel)

4. * Klein A, Schwartz H, Sagi-Assif O, Meshel T, Izraely S, Ben Menachem S, Bengaiev R, Ben-Shmuel A, Nahmias C, Couraud PO, Witz IP, Erez N. Astrocytes facilitate melanoma brain metastasis via secretion of IL-23. J Pathol. 236 :116-127 (2015). (* Israel)

5. * Zubrilov I, Sagi-Assif O, Izraely S, Meshel T, Ben-Menahem S, Ginat R, Pasmanik-Chor M, Nahmias C, Couraud PO, Hoon DS, Witz IP. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells. Cancer Lett. 361 :86-96 (2015). (*Israel)


1. * Authier H, Billot K, Derudder E, Bordereaux D, Rivière P, Rodrigues-Ferreira S, Nahmias C, Baud V. IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors. Proc Natl Acad Sci (U S A). Oct 14;111(41):14794-9 (2014) (*France)

2. Rodrigues-Ferreira S, Molina A, Nehlig A, Nahmias C. The AT2 receptor and interacting proteins ATIPs in cancer. in « The protective arm of the renin angiotensin system », Chapitre de livre, Editeur Elsevier (2014).

3. Nahmias C and Rodrigues-Ferreira S. Angiotensin II in Breast Cancer Metastasis: Strategy, Tools and Models Towards New Cancer Therapies. Chapitre de livre, Editeur i-concept (2014)




- Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint A-C, Bouhlel I, Morel M, Sapharikas E, Di Tommaso A, Honoré S, Braguer D, Gruel N, Vincent-Salomon A, Delattre O, Sigal-Zafrani B, André F, Terris B, Akhmanova A, Di Benedetto M, Nahmias C*, Rodrigues-Ferreira S*. [*Equal contribution]. ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics. Cancer Research 73(9):2905-15 (2013).

- Rodrigues-Ferreira S, Le Rouzic E, Pawlowski T, Srivastava A, Margottin-Goguet F, Nahmias C. AT2 receptor-interacting proteins ATIPs in the brain. Int. J. Hypertension vol 2013, IDD 513047, 6 pages, (2013)


- Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C. Angiotensin II facilitates breast cancer cell migration and metastasis. PLoS One. 7(4):e35667 (2012).

- Rodrigues-Ferreira S, Morel M, Reis RI, Cormier F, Baud V, Costa-Neto CM, Nahmias C. A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells. Int J Pept. 2012:745027 (2012).

* Klein A, Sagi-Assif O, Izraely S, Meshel T, Pasmanik-Chor M, Nahmias C, Couraud PO, Erez N, Hoon DS, Witz IP. The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells. Int J Cancer. doi: 10.1002/ijc.27552 (2012). (* Israel).

*Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M, Nahmias C, Couraud PO, Ateh E, Bryant JL, Hoon DS, Witz IP. The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer. 2012 Sep 1;131(5):1071-82 (2012). (* Israel).


- Molina A, Rodrigues-Ferreira S, Di Tommaso A, Nahmias C. ATIP, a novel superfamily of microtubule-associated proteins. Med Sci (Paris) 27(3):244-6 (2011). French.

- Abdelkarim M, Vintonenko N, Starzec A, Robles A, Aubert J, Martin ML, Mourah S, Podgorniak MP, Rodrigues-Ferreira S, Nahmias C, Couraud PO, Doliger C, Sainte-Catherine O, Peyri N, Chen L, Mariau J, Etienne M, Perret GY, Crepin M, Poyet JL, Khatib AM, Di Benedetto M. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype. PLoS One. 6(8):e23334 (2011). (* France).


- Rodrigues-Ferreira S, Nahmias C. An ATIPical family of angiotensin II AT2 receptor-interacting proteins. Trends Endocrinol Metab. 21(11):684-90 (2010). Review.


- Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinié V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One. 4(10):e7239 (2009).

- * Fujita T, Mogi M, Min LJ, Iwanami J, Tsukuda K, Sakata A, Okayama H, Iwai M, Nahmias C, Higaki J, Horiuchi M. Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1. Hypertension 53(4):688-93 (2009). (* Japon).

- * Chow L, Rezmann L, Catt KJ, Louis WJ, Frauman AG, Nahmias C, Louis SN. Role of the renin-angiotensin system in prostate cancer. Mol Cell Endocrinol. 302(2):219-29 (2009).  (* Australie).


- Strosberg AD, Nahmias C. G-protein-coupled receptor signalling through protein networks. Biochem Soc Trans. 35(Pt 1):23-7 (2007) Review.

- * Li JM, Mogi M, Tsukuda K, Tomochika H, Iwanami J, Min LJ, Nahmias C, Iwai M, Horiuchi M. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol. 21(2):499-511 (2007). (* Japon).

 - Di Benedetto M, Bièche I, Deshayes F, Vacher S, Nouet S, Collura V, Seitz I, Louis S, Pineau P, Amsellem-Ouazana D, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Lidereau R, Nahmias C. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380(2):127-36 (2006).

- Di Benedetto M, Pineau P, Nouet S, Berhouet S, Seitz I, Louis S, Dejean A, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Nahmias C. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol Cell Endocrinol. 252(1-2):207-15 (2006).

- Cazaubon S, Deshayes F, Couraud PO, Nahmias C. Endothelin-1, angiotensin II and cancer. Med Sci (Paris). 22(4):416-22 (2006). Review. French.

- Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab. 16(7):293-9 (2005). Review.

- Nouet S, Amzallag N, Li JM, Louis S, Seitz I, Cui TX, Alleaume AM, Di Benedetto M, Boden C, Masson M, Strosberg AD, Horiuchi M, Couraud PO, Nahmias C. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem. 279(28):28989-97 (2004).